Nathan Treybeck
Stock Analyst at Wells Fargo
(2.14)
# 2,901
Out of 5,124 analysts
21
Total ratings
50%
Success rate
8.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $83.04 | +11.99% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $31.53 | +61.75% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $78.34 | +2.12% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $243.08 | +15.19% | 1 | Oct 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $180 | $178.75 | +0.70% | 5 | Aug 1, 2025 |
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $83.04
Upside: +11.99%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $31.53
Upside: +61.75%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $78.34
Upside: +2.12%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $243.08
Upside: +15.19%
iRhythm Technologies
Aug 1, 2025
Maintains: Overweight
Price Target: $130 → $180
Current: $178.75
Upside: +0.70%